ABSTRACT: Cross-linking of nucleic acids to proteins in combination with mass spectrometry permits the precise identification of interacting residues between nucleic acid-protein complexes. However, the mass spectrometric identification and characterisation of cross-linked nucleic acid-protein heteroconjugates within a complex sample is challenging. Here we establish a novel enzymatic differential 16 O/ 18 O labelling approach, which uniquely labels heteroconjugates. We have developed an automated data analysis workflow based on OpenMS for the identification of differentially isotopically labelled heteroconjugates against a complex background. We validated our method using synthetic model DNA oligonucleotide-peptide heteroconjugates which were subjected to the labelling reaction and analysed by high resolution FT-ICR mass spectrometry.
UV cross-linking in combination with mass spectrometry is a powerful technique which can be applied to nucleic acidprotein complexes in order to identify proteins, peptides and the amino acids involved in intermolecular interactions within nucleic acid-protein complexes 1, 2 . Non-covalent nucleic acidprotein interactions are firstly stabilized by UV cross-linking to form covalent heteroconjugates. Following protease and nuclease digestion and an enrichment step, such heteroconjugates can then be characterised by mass spectrometry to identify the cross-linked peptides and amino acids. However, the mass spectrometric identification of cross-linked nucleic acid-protein heteroconjugates within a complex mixture is still challenging and cannot be performed by conventional MS search engines. Here we introduce a novel sequential differential enzymatic 16 O/ 18 O isotope labelling strategy which has been designed to facilitate the mass spectrometric identification of oligonucleotide-peptide heteroconjugates, allowing them to be readily distinguished from non-cross-linked peptides and their detection can be easily automated.
Normally following UV cross-linking, heteroconjugates are digested with trypsin resulting in a mixture of oligonucleotidepeptide heteroconjugates and non-cross-linked peptides and oligonucleotides. To establish this method we have used synthetic model DNA oligonucleotide-peptide heteroconjugates 3 , labelled them using our differential labelling approach described in Figure 1 and, then analysed them by high resolution Fourier transform ion cyclotron resonance (FT-ICR) mass spectrometry.
Firstly, heteroconjugates are labelled by post-digestion trypsin catalysed labelling in the presence of either H2 16 In addition, we have developed an OpenMS data analysis pipeline in which the detection of 6 Da doublets is automated, therefore allowing the easy identification of differentially labelled nucleic acid-peptide heteroconjugates within a LC/MS data set. Thus a complete workflow for the labelling and detection of nucleic acid-peptide heteroconjugates is illustrated which is applicable to any nucleic acid-protein cross-linking study.
MATERIALS AND METHODS

Chemicals, Solvents and Reagents
All chemicals, solvents and reagents were purchased from Sigma-Aldrich or Fisher Scientific. For mass spectrometry, solvents were of LC/MS grade or higher. For all stable isotope labelling experiments, H2
18 O (97% Cambridge Stable Isotope Laboratories, Inc, USA) was used to prepare all buffers and labelling solutions (except where stated). The synthetic heteroconjugates were synthesized as described previously 3 .
For all heteroconjugates the 20-mer oligonucleotide (5′GTAGAGGATCTAAAAGACXT-Biotin-TEG3′), where X was 5-ethynyl-2'-deoxyuridine (5EdU), was purchased from BaseClick, Germany.
For heteroconjugate HC20-A, the peptide (LDIAFGTF*ATK), where F* was 4-azidophenylalanine, was purchased from Eurogentec, UK. For heteroconjugates HC20-B, HC20-C and HC20-D, peptides B (LDNAHF*GDATK), C (LDFAHF*GDATK) and D, (LDNSHF*GDATK) were synthesised in-house. For click chemistry, the Oligo-Click Kit was used as per the manual (BaseClick, Germany) and as described previously.
Trypsin Catalyzed Labelling of HC20-A
Two reactions were set up in parallel to label HC20-A with either 16 O or 18 O. Prior to labelling, 500 pmol of HC20-A was washed in 3 x 10 µL H2
16 O or H2 18 O, then reduced to dryness using a speed vac. For labelling, HC20-A was reconstituted in 50 µL (10 µM) containing 50 mM NH4HCO3, 10 mM CaCl2 and 2 µg trypsin (Sequencing Grade Modified Trypsin, Promega, 1 µg/µL stock dissolved in 50 mM NH4HCO3). Reactions were incubated at 37°C for 5 hours, then 10 µL of each reaction was analysed by RP-HPLC/ESI-FT-ICR-MS in negative mode as described previously for HC20-A 3 .
Nuclease P1 Labelling of HC20-A Two reactions were set up in parallel to digest and label HC20-A with either 16 O or 18 O. Prior to labelling, 200 pmol of HC20-A was washed as described above. For labelling, HC20-A was reconstituted in 20 µL (10 µM) containing 50 mM NH₄C₂H₃O₂, pH 5.2, 100 nM ZnCl2 and 0.1 units nuclease P1 (N8630, Sigma-Aldrich, 250 units dissolved in 1 mL H2
16 O) Reactions were incubated at 50°C for 30 min then 10 µL of each reaction was analysed individually by monolith-HPLC/ESI-FT-ICR-MS in positive mode as described below.
Differential Sequential Labelling of Heteroconjugates
All labelling reactions were set up in parallel for H2 16 O and H2
18 O: either a pure sample of 500 pmol of HC20-A in H2O; or, samples containing the indicated mixtures of HC20-A, HC20-B, HC20-C and HC20-D, in molar ratios of 1:1, 1:2 or 1:5 with BSA tryptic peptides (10 µM BSA pre-digested) in 50 mM NH4HCO3, in either 16 O or 18 O. Trypsin catalysed labelling of all samples was then performed as described above, in 50 µL (10 µM of each heteroconjugate and 10, 20 or 50 µM pre-digested BSA). Following trypsin labelling samples were incubated at 100°C for 10 min and phenylmethylsulfonyl fluoride was added to a final concentration of 1 mM. Samples were then reduced to dryness using a speed vac and digested with nuclease P1 as described above but in 50 µL (10 µM 
FT-ICR Mass Spectrometry
Analysis was performed using reverse-phase high performance liquid chromatography (RP-HPLC) using an U3000 HPLC system (Dionex, UK) coupled to the standard electrospray source (Bruker Daltonics) and a SolariX FTICR mass spectrometer equipped with a 12 T superconducting magnet (BrukerDaltonics). Acquisition of LC/MS data was controlled by HyStar, version 3.4, build 8 (Bruker Daltonics).
For analysis of labelled HC20-A in negative mode, analysis was performed as described previously 3 .
For analysis of nuclease P1 digested and labelled, RP-HPLC was performed using a monolith column (500 µm x 50 mm pepswift poly(styrene/divinyl benzene) (PSDVB) column, Thermo Finnigan, USA). Ten µL of 10 µM 16 O or 18 O labelled sample HC20-A was injected, or ten µL of 5 µM 16 O and 18 O labelled sample HC20-A+B+C+D within a BSA tryptic digest. Heteroconjugates were analysed in positive mode using buffer A, 0.1% formic acid, and buffer B, 0.1% formic acid in 100% acetonitrile. Using a flow rate of 20 μL/min at 60°C, the column was first run at 0% B for 2 min, followed by a linear ramp from 0% to 100% B from 2 to 20 min. The column was then washed with 100% B from 20 to 25 min, then with 0% B from 25 to 30 min.
For electrospray ionization, gas pressure was typically ~2.2 psi and spray voltage was 4.5 kV. For mass spectrometry, ion accumulation times was typically 0.3 s. Ions were trapped using a 6 cm × 10 cm Infinity cell. Each individual LC/MS spectrum was the sum of two acquisitions. Transient data size was typically 1 or 2 Mword for each acquisition, and sine-bell multiplication apodization was applied to each transient during FT-MS postprocessing. All mass spectra were analyzed using DataAnalysis software version 4.1 SR1 build 362.7 (Bruker Daltonics)
OpenMS Data Analysis Pipeline
Data was exported to mzML files using CompassXport 3.0 (Bruker Daltonics). The mzML files formed the input for the data analysis pipeline outlined in Figure 2 . To reduce the impact of low intensity signals on doublet detection, a signal processing step was performed that retains the highest intensity mass peak in a sliding window of size 0.2 Thomson using the OpenMS tool SpectraFilterWindowMower 4, 5 . In the second step of the pipeline, we configure the tool FeatureFinderMultiplex 6 to detect eluting species exhibiting the characteristic 6 Da shift with m/z tolerance set to 5 ppm. The FileFilter tools then discarded all detected singlets and only doublets were retained. The list of 6 Da doublets is then exported to a tabular text file using the TextExporter tool. Figure 2 . Overview of the data processing pipeline. Raw data is exported and input into the automated OpenMS data processing workflow (shaded boxes). Each node corresponds to an OpenMS pipeline tool (name in italic letters) that performs a distinct data processing step. Detected doublets are then written as tabular file and can be inspected using a spreadsheet application.
RESULTS
Trypsin-Catalysed Labelling of Heteroconjugates
Serine proteases including trypsin, LysC and GluC, can catalyse the incorporation of two 18 O atoms at the carboxylterminus of a proteolytic peptide in the presence of the heavy isotopic form of water H2
18 O 7 . For 18 O labelling, proteolytic digestion can be decoupled from enzyme catalysed oxygen exchange 8 , which offers the advantage that both reactions can be performed separately. Therefore post digestion trypsin catalysed oxygen exchange can be optimised to promote the incorporation of two 18 O atoms and achieve a high labelling efficiency, which is required for the differential labelling strategy.
To demonstrate efficient post-digestion trypsin-catalysed 18 O labelling of DNA-peptide heteroconjugates, two labelling reactions were set up in parallel to label a synthetic DNA oligonucleotide-peptide heteroconjugate HC20-A with either 16 O or 18 O, and then analysed individually by RP-HPLC/ESI-FT-ICR mass spectrometry in negative mode ( Figure 3A) .
In the presence of H2 18 O, the monoisotopic peak of HC20-A was increased in mass by 4 Da following the incorporation of two 18 O atoms into the C-terminus of the peptide moiety, to form the I4 isotopomer. The high mass resolving power of FT-ICR mass spectrometry allowed the clear distinction between the I0 and I4 isotopomers. The associated change in mass did not affect the HPLC retention time of the HC20-A. O, and then analysed individually by RP-HPLC/ESI-FT-ICR mass spectrometry in positive mode ( Figure 3B ). In the presence of 95% H2 18 O, the monoisotopic peak of the digested HC20-A had increased in mass by 2 Da following the incorporation of a single 18 O label into the remaining 5' monophosphate, to form the I2 isotopomer. Although very efficiently labelled, 18 O labelling to form the I2 isotopomer was not 100%, with some I0 isotopomer also present ( Figure 3B , annotated with an asterisk), likely due to the occurrence of minimal back exchange with residual 16 O. Again, the associated change in mass did not affect the retention time of the digested HC20-A. In conclusion, HC20-A can be 16 O/ 18 O labelled by either trypsin introducing a 4 Da shift or nuclease P1 introducing a 2 Da shift.
Differential Sequential Labelling of Heteroconjugates
To uniquely label heteroconjugates with 18 O3, we next combined both the trypsin and nuclease P1 labelling steps. To demonstrate this, two reactions were performed in parallel to label heteroconjugate HC20-A with either 16 O3 or 18 O3. Trypsin catalysed 18 O labelling was performed first, and following this, to prevent digestion of nuclease P1 in the next step, trypsin was chemically and heat inactivated. Next, nuclease P1 catalysed 18 O labelling was performed. Samples were then were analysed individually and mixed 1:1, and analysed by RP-HPLC/ESI-FT-ICR mass spectrometry in positive mode. In the presence of H2 18 O, the monoisotopic peak of HC20-A was increased in mass by 6 Da following the dual labelling approach (Figure 4A and 4B) to form the I6 isotopomer. When the labelled samples were mixed 1:1 prior to analysis, the heteroconjugate was detected as a doublet, with the co-eluting I0 and the I6 isotopomers, 6 Da apart, within a single LC/MS run (Figure 4, lower spectrum) .
In a UV cross-linking experiment, heteroconjugates are present within a complex sample containing a background of non-cross-linked species. Therefore, to ensure differential labelling of heteroconjugates was efficient within a more complex sample, we next performed differential labelling of HC20-A within a tryptic digest of BSA. In addition to HC20-A we employed a range of heteroconjugates which varied in their overall sequence and charge to ensure labelling and detection was not restricted to HC20-A. Differential labelling was performed as previously. Heteroconjugates HC20-A, -B -C and -D were observed to elute at 8.0, 6.4, 7.4 and 6.4 min respectively as indicated on the total ion chromatogram shown in Figure 5 . All four heteroconjugates were efficiently labelled and observed as unique doublets within this complex sample. In Figure 5B , the mass spectrum at 6.4 min is shown, in which, both, differentially labelled HC20-B and differentially labelled HC20-D were present as unique 6 Da doublets within this spectrum. In conclusion, a range of heteroconjugates can be uniquely and efficiently labelled within a more complex sample using a two-step differential labelling approach.
Detection of Differentially Labelled Heteroconjugates
In the experiments described above, differentially labelled heteroconjugate doublets were easily identified as we employed defined synthetic model heteroconjugates. However finding unknown doublets in a real cross-linking experiment, is a challenging task. To automate the detection of differentially labelled doublets and allow the efficient detection of potential heteroconjugate species, we developed an OpenMS data analysis pipeline. Doublets detected by the pipeline represent potential heteroconjugate precursor ions which could then be further characterised and confirmed by MS/MS analysis. If the detected doublet is a true heteroconjugate, fragmentation of both the light and heavy labelled species would give complementary labelled fragment spectra. The 18 O labelling may also aid in sequencing of the nucleic acid-peptide heteroconjugates, similar to its application for peptide and cross-linked peptide de novo sequencing 9, 10 .
To test the data analysis pipeline, data was analysed from samples in which equimolar mixtures of BSA tryptic peptides and HC20-B, HC20-C and HC20-D were differentially labelled in triplicate and analysed by LC/MS. The pipeline detected four 6 Da doublet species which were present in all three replicates whereas no doublets were detected in control samples containing only labelled BSA peptides. The detected (Table 1) . HC20-C was not detected, but manual inspection of the data revealed that a highly abundant BSA peptide with a similar mass coeluted with HC20-C, which resulted in an overlapping isotopic distribution and interfered with the detection of HC20-C by the pipeline. This highlights the importance of enrichment strategies which are required in all cross-linking workflows to remove the majority of excess non-cross-linked species and thus enable the identification of cross-linked heteroconjugates 1, 2 . To test if our labelling strategy is compatible with enrichment methods and if enrichment could improve the detection of heteroconjugates, the samples were enriched by using titanium dioxide columns 11 . Importantly, the 6 Da label of heteroconjugates was maintained following enrichment, and in addition, HC20-C could now be detected by the pipeline (Table 1) . Table 1 . Heteroconjugates detected by the OpenMS pipeline, with and without titanium dioxide enrichment, In a true cross-linking experiment, owing to low crosslinking efficiency, heteroconjugates are present in substochiometric amounts compared with non-cross-linked peptides. Therefore the pipeline was tested using different molar ratio's of BSA peptides: heteroconjugates. At a ratio of 2:1, the pipeline detected HC20-B and HC20-D (Table 1) . However with a larger excess of BSA peptides at 5:1, only a single HC20-B [M+2H] 2+ ion was detected, Following titanium dioxide enrichment, a further three heteroconjugates ions were detected (Table 1) . Titanium dioxide enrichment increased the sensitivity of the detection in every scenario tested.
In conclusion, the OpenMS-based analysis pipeline efficiently detects differentially labelled heteroconjugates within an LC/MS data set. In cross-linking experiments, candidate heteroconjugate species could be confirmed with targeted MS/MS approaches. Lastly, our labelling stratey is compatible with standard heteroconjugate enrichment protocols, a key step in all cross-linking workflows.
DISCUSSION
UV cross-linking and mass spectrometry is a useful method to characterise interactions in different nucleic acid-protein complexes 1, 2 . However, the identification of heteroconjugates is a challenging task. We have developed a novel isotopic differential labelling strategy to uniquely label heteroconjugates and enable their detection by an OpenMS data analysis pipeline by the presence of isotopic doublets. This labelling approach could also be used to complement and increase confidence in heteroconjugates identified by the recently developed software program RNPxl. RNPxl detects heteroconjugates by calculating and searching for a variety of nucleic acid modifications 12 . Length and composition of nucleic acid moieties remaining after nuclease digestion are variable and any amino acid could potentially be cross-linked. Therefore, a large number of nucleic acid modifications must be considered in RNPxl database search, and conventional search engines are not suitable for such analysis.. Nuclease P1 digestion alone can uniquely label heteroconjugates. However, automated detection of 2 Da differentially labelled heteroconjugates doublets is challenging due to the overlapping isotope distributions of the I0 and I2 isotopomers. We therefore combined both the trypsin and nuclease P1 labelling steps to uniquely label heteroconjugates (with 6 Da), and provide optimal resolution between the isotope distributions of the I0 and I6 isotopomers. In addition, the 6 Da shift is small enough to allow accurate detection of the mass difference using high resolution mass spectrometry. Labelling heteroconjugates with 18 O3 (6 Da) allows them to be easily distinguished from contaminants such as non-crosslinked (but labelled) peptides (4 Da) and nucleic acids (2 Da) which are commonly present in cross-linking samples, even following heteroconjugate enrichment. This labelling approach is applicable to existing methods published thus far for generating nucleic acid-peptide heteroconjugates, as it exploits the protease and nuclease digestion steps necessary for the sample preparation of heteroconjugates. This method can detect heteroconjugates with a variety of nucleic acid modifications which have been UV cross-linked with native DNA or photoactivatable DNA, or cross-linked chemically, and does not require that the crosslinking mechanism and any associated losses are known in advance. It also does not require specially synthesized, isotopically labelled nucleic acids 13 , therefore would be suitable for cross-linking experiments using any synthetic nucleic acid as well as nucleic acids in or isolated from cells. Synthetic heteroconjugates as described here may be included to serve as internal controls for efficient labelling and enrichment. This labelling approach is relevant to both the study of DNA-protein and RNA-protein heteroconjugates, and would be compatible with other serine proteases and nucleases which act by a hydrolysis mechanism. Lastly, the steps of protease and nuclease labelling are flexible and could be reversed or incorporated at any stage within the sample preparation and enrichment protocol as appropriate for the user. In conclusion, the differential labelling approach introduced and developed here facilitates the identification of cross-linked nucleic acid-peptide heteroconjugates by mass spectrometry.
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